Additional Listing

RNS Number : 3323E

Assura PLC

06 July 2021

 

6 July 2021

Assura plc

Additional Listing

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that 867,377 New Ordinary Shares (the "New Shares") have been issued to the Assura plc Employee Benefit Trust in order to satisfy the awards pursuant to the 2018 Performance Share Plan (636,443) and also restricted share awards pursuant to the Performance Share Plan (230,934).

Application has therefore been made for the admission of the New Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 7 July 2021.

Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,676,414,861 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,676,414,861.

For more information, please contact:

Assura plc Orla Ball, Company Secretary David Purcell, Head of Investor Relations	Tel: [phone] Email: [e-mail]
Finsbury Gordon Simpson James Thompson	Tel: [phone] Email: [e-mail]

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2021, Assura's property portfolio was valued at £2,453 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

Assura plc LEI code: 21380026T19N2Y52XF72

 

END

 

 

ALSUPURWMUPGGUQ